Amedisys Inc., a national home health and hospice company based in Baton Rouge, reported an adjusted fourth-quarter profit of $9.1 million, or 28 cents per share, compared to a loss of $9.6 million, or 30 cents per share, a year ago.
Amedisys said its revenue dipped to $300.5 million, compared to $303.5 million a year earlier.
For 2014, Amedisys recorded a profit of $12.8 million, or 39 cents per share, compared to a loss of $96.2 million, or $3.08 per share, for 2013. Amedisys's 2014 revenue was $1.20 billion, down from $1.25 billion a year earlier.
However, the 2013 figures were lowered by a $150 million settlement with the U.S. Justice Department involving the company's Medicare billing practices.
The company beat Wall Street's earnings forecasts for the quarter but fell just short of revenue projections. Stock analysts surveyed by Thomson Reuters expected earnings of 26 cents per share on revenue of $301.6 million.
Amedisys also fell short of analysts' annual projections. For the year, analysts had projected earnings of 72 cents per share on revenue of 1.21 billion.
However, the 2014 figures include a number of other charges, including lease $10 million in restructuring fees and $4 million for "relator" or whistleblower fees. The Justice Department settlement included $15 million for a former employee who reported the company for its billing practices.
Without those charges, Amedisys would have earned $23.9 million, or 73 cents per share.